Back to LA LINDEN ADVISORS LP

BRBRIDGEBIO PHARMA INC

Showing 8 of 12 quarters

Position history for LALINDEN ADVISORS LP's holdings in BRIDGEBIO PHARMA INC

Current Value

$266.3M

Current Shares

239.7M

Total Value Change

+$192.5M

Total Shares Change

+151.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
239.7M
+0.3%
$266.3M1.4%—
48
2026-Q1
Increased
239M
+11.7%
$268.5M1.5%—
54
2025-Q4
Increased
214M
+22.3%
$241M1.5%—
58
2025-Q3
Increased
175M
+18.2%
$173.1M1.2%—
56
2025-Q2
Increased
148M
+8.2%
$138.6M0.9%—
46
2025-Q1
Increased
136.8M
+33.8%
$123.2M0.8%—
55
2024-Q4
Increased
102.2M
+15.9%
$87.5M0.7%—
48
2024-Q3
Increased
88.2M
+7.3%
$73.8M0.6%—
45

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used